Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- mice.

Bot I, Bot M, van Heiningen SH, van Santbrink PJ, Lankhuizen IM, Hartman P, Gruener S, Hilpert H, van Berkel TJ, Fingerle J, Biessen EA.

Cardiovasc Res. 2011 Jan 1;89(1):244-52. doi: 10.1093/cvr/cvq260. Epub 2010 Aug 6.

PMID:
20693162
2.

Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.

Lee M, Calabresi L, Chiesa G, Franceschini G, Kovanen PT.

Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1475-81.

3.

Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

Yukawa K, Tanaka T, Kishino M, Yoshida K, Takeuchi N, Ito T, Takamatsu H, Kikutani H, Kumanogoh A.

Int J Mol Med. 2010 Jul;26(1):39-44.

PMID:
20514420
4.
5.

Feeding a thermally oxidised fat inhibits atherosclerotic plaque formation in the aortic root of LDL receptor-deficient mice.

Kämmerer I, Ringseis R, Eder K.

Br J Nutr. 2011 Jan;105(2):190-9. doi: 10.1017/S0007114510003478. Epub 2010 Sep 21.

PMID:
20854700
6.

Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice.

Van Herck JL, De Meyer GR, Martinet W, Bult H, Vrints CJ, Herman AG.

Basic Res Cardiol. 2010 Jan;105(1):39-50. doi: 10.1007/s00395-009-0054-y. Epub 2009 Aug 20.

PMID:
19693627
7.

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, Luthringer D, Xu XP, Rajavashisth TB, Yano J, Kaul S, Arditi M.

Circulation. 2001 Dec 18;104(25):3103-8.

8.

[Effects of FOXP3 on the progression of atherosclerosis plaque in ApoE-knock out mice].

Wang ZX, Lin J, Chen B, He SL, Ma XM, Li DZ.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Feb;27(2):154-7. Chinese.

PMID:
21315044
9.

Emodin promotes atherosclerotic plaque stability in fat-fed apolipoprotein E-deficient mice.

Zhou M, Xu H, Pan L, Wen J, Guo Y, Chen K.

Tohoku J Exp Med. 2008 May;215(1):61-9.

10.

Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation.

Lagraauw HM, Westra MM, Bot M, Wezel A, van Santbrink PJ, Pasterkamp G, Biessen EA, Kuiper J, Bot I.

Atherosclerosis. 2014 Jul;235(1):196-203. doi: 10.1016/j.atherosclerosis.2014.04.025. Epub 2014 May 10.

PMID:
24858338
11.

Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.

Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2333-40.

12.

Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression.

Roselaar SE, Kakkanathu PX, Daugherty A.

Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1013-8.

13.

Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.

Reddy ST, Nguyen JT, Grijalva V, Hough G, Hama S, Navab M, Fogelman AM.

Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1676-81. Epub 2004 Jul 8.

14.

Lentivirus-mediated RNA interference of chymase increases the plaque stability in atherosclerosis in vivo.

Guo T, Wang J, Yang J, Chen W, An G, Fan L, Peng Q.

Exp Mol Pathol. 2013 Aug;95(1):51-6. doi: 10.1016/j.yexmp.2013.05.005. Epub 2013 May 24.

PMID:
23712028
15.

Effects of exercise training on the severity and composition of atherosclerotic plaque in apoE-deficient mice.

Kadoglou NP, Kostomitsopoulos N, Kapelouzou A, Moustardas P, Katsimpoulas M, Giagini A, Dede E, Boudoulas H, Konstantinides S, Karayannacos PE, Liapis CD.

J Vasc Res. 2011;48(4):347-56. doi: 10.1159/000321174. Epub 2011 Mar 9.

PMID:
21389732
16.

Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice.

Bot I, de Jager SC, Zernecke A, Lindstedt KA, van Berkel TJ, Weber C, Biessen EA.

Circulation. 2007 May 15;115(19):2516-25. Epub 2007 Apr 30.

17.

Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.

Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, Tang X, Ren Y, Tang C, Du J.

Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):173-9. doi: 10.1161/ATVBAHA.108.179333. Epub 2008 Nov 6.

18.
19.

Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis.

Guo T, Chen WQ, Zhang C, Zhao YX, Zhang Y.

Atherosclerosis. 2009 Nov;207(1):59-67. doi: 10.1016/j.atherosclerosis.2009.04.014. Epub 2009 Apr 17.

PMID:
19446292
20.

Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.

Howard PS, Renfrow D, Schechter NM, Kucich U.

Neurourol Urodyn. 2004;23(4):374-82.

PMID:
15227657

Supplemental Content

Support Center